161 related articles for article (PubMed ID: 4842658)
1. Effect of a butyrophenone derivative, U-32,802A, on brain biogenic amines.
Lahti RA; Lednicer D
Biochem Pharmacol; 1974 Jun; 23(12):1701-5. PubMed ID: 4842658
[No Abstract] [Full Text] [Related]
2. Production of catalepsy and depletion of brain monoamines by a butyrophenone derivative.
Fuenmayor LD; Vogt M
Br J Pharmacol; 1979 Sep; 67(1):115-22. PubMed ID: 574039
[TBL] [Abstract][Full Text] [Related]
3. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
Yang HY; Neff NH
J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
[No Abstract] [Full Text] [Related]
4. The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse.
Wenger GR; Stitzel RE; Craig CR
Neuropharmacology; 1973 Jul; 12(7):693-703. PubMed ID: 4147164
[No Abstract] [Full Text] [Related]
5. Studies related to the cholinergic influence on the accumulation and disappearance of monoamines in rat brain.
Bhatnagar SP
Can J Physiol Pharmacol; 1973 Dec; 51(12):893-9. PubMed ID: 4777240
[No Abstract] [Full Text] [Related]
6. Release of biogenic amines from isolated nerve endings.
Raiteri M; Bertollini A; del Carmine R; Levi G
Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741
[No Abstract] [Full Text] [Related]
7. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
Symchowicz S; Korduba CA; Veals J
Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
[No Abstract] [Full Text] [Related]
8. Effects of the optical isomers of the narcotic antagonist analgesic pentazocine on brain and heart biogenic amines.
Berkowitz BA
Eur J Pharmacol; 1974 May; 26(2):359-65. PubMed ID: 4152866
[No Abstract] [Full Text] [Related]
9. A comparison of the neurochemical effects of buprenorphine with those of morphine and haloperidol in rats.
Dettmar PW; Cowan A; Walter DS
Eur J Pharmacol; 1981 Jan; 69(2):147-53. PubMed ID: 7202515
[No Abstract] [Full Text] [Related]
10. Proceedings: Turnover of biogenic amines after acute and chronic morphine treatment in rats.
Theiss P; Papeschi R
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R98. PubMed ID: 4276659
[No Abstract] [Full Text] [Related]
11. Effect of nomifensine (HOE 984), a new antidepressant, on uptake of noradrenaline and serotonin and on release of noradrenaline in rat brain synaptosomes.
Schacht U; Heptner W
Biochem Pharmacol; 1974 Dec; 23(24):3413-22. PubMed ID: 4441422
[No Abstract] [Full Text] [Related]
12. Critical notes on the specificity of drugs in the study of metabolism and functions of brain monoamines.
Garattini S; Mennini T
Int Rev Neurobiol; 1988; 29():259-80. PubMed ID: 3042665
[No Abstract] [Full Text] [Related]
13. The inhibition of (3H) biogenic amine accumulation into rat brain tissue slices by various tryptamine derivatives.
Heikkila RE; Cohen G
Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):539-47. PubMed ID: 4824828
[No Abstract] [Full Text] [Related]
14. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
[TBL] [Abstract][Full Text] [Related]
15. 6-Hydroxydopamine: effect on mouse brain monoamines and 14C-noradrenaline uptake.
Masuoka DT; Alcaraz AF
Eur J Pharmacol; 1973 Nov; 24(2):234-42. PubMed ID: 4765746
[No Abstract] [Full Text] [Related]
16. Venezuelan equine encephalomyelitis virus infection: effect on monoamine metabolism of mouse brain.
Bonilla E; Ryder S; Hernandez H
J Neurochem; 1975 Oct; 25(4):529-30. PubMed ID: 1151388
[No Abstract] [Full Text] [Related]
17. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders].
Anokhina IP; Gamaleia NB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209
[No Abstract] [Full Text] [Related]
18. Effect of deserpidine and pargyline on the levels of biogenic amines in brain, liver and heart of mice.
Everett GM; Borcherding J; Morse P
Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):245-8. PubMed ID: 4679851
[No Abstract] [Full Text] [Related]
19. Interactions of pentazocine and naloxone on the monoamine content of discrete regions of the rat brain.
Holtzman SG
Biochem Pharmacol; 1974 Nov; 23(21):3029-35. PubMed ID: 4429600
[No Abstract] [Full Text] [Related]
20. Drugs affecting monoamines in the basal ganglia.
Bartholini G; Pletscher A
Adv Biochem Psychopharmacol; 1972; 6():135-48. PubMed ID: 4560163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
